Literature DB >> 7815888

Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation.

P Limousin1, P Pollak, A Benazzouz, D Hoffmann, J F Le Bas, E Broussolle, J E Perret, A L Benabid.   

Abstract

In monkeys rendered parkinsonian, lesions and electrical stimulation of the subthalamic nucleus reduce all major motor disturbances. The effect of electrical stimulation of the subthalamic nucleus was assessed in three patients with disabling akinetic-rigid Parkinson's disease and severe motor fluctuations. Quadripolar electrodes connected to a pulse generator were implanted in the subthalamic nuclei on both sides. Patients were evaluated with the unified Parkinson's disease rating scale and timed motor tests. 3 months after surgery, activities of daily living scores had improved by 58-88% and motor scores by 42-84%. This improvement was maintained for up to 8 months in the first patient operated upon. One patient was confused for 2 weeks after surgery, and another developed neuropsychological impairment related to a thalamic infarction which improved over 3 months. In one patient, stimulation could induce ballism that was stopped by reduction of stimulation. This is the first demonstration in human beings of the part played by the subthalamic nuclei in the pathophysiology of Parkinson's disease.

Entities:  

Mesh:

Year:  1995        PMID: 7815888     DOI: 10.1016/s0140-6736(95)90062-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  237 in total

1.  Improvement of levodopa induced dyskinesias by thalamic deep brain stimulation is related to slight variation in electrode placement: possible involvement of the centre median and parafascicularis complex.

Authors:  D Caparros-Lefebvre; S Blond; M P Feltin; P Pollak; A L Benabid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-09       Impact factor: 10.154

2.  Acute and chronic effects of anteromedial globus pallidus stimulation in Parkinson's disease.

Authors:  F Durif; J J Lemaire; B Debilly; G Dordain
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-09       Impact factor: 10.154

Review 3.  Recent Advances. Neurology.

Authors:  A J Larner; S F Farmer
Journal:  BMJ       Date:  1999-08-07

4.  Cognitive functioning after subthalamic nucleotomy for refractory Parkinson's disease.

Authors:  R J McCarter; N H Walton; A F Rowan; S S Gill; M Palomo
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-07       Impact factor: 10.154

5.  Activation of group II metabotropic glutamate receptors inhibits synaptic excitation of the substantia Nigra pars reticulata.

Authors:  S R Bradley; M J Marino; M Wittmann; S T Rouse; H Awad; A I Levey; P J Conn
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

6.  Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus.

Authors:  H Awad; G W Hubert; Y Smith; A I Levey; P J Conn
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

7.  Deep brain stimulation of the subthalamic nucleus: anatomical, neurophysiological, and outcome correlations with the effects of stimulation.

Authors:  M M Lanotte; M Rizzone; B Bergamasco; G Faccani; A Melcarne; L Lopiano
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-01       Impact factor: 10.154

8.  Enhanced food-related motivation after bilateral lesions of the subthalamic nucleus.

Authors:  Christelle Baunez; Marianne Amalric; Trevor W Robbins
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

9.  High-frequency synchronization of neuronal activity in the subthalamic nucleus of parkinsonian patients with limb tremor.

Authors:  R Levy; W D Hutchison; A M Lozano; J O Dostrovsky
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

Review 10.  Cell replacement therapy is the remedial solution for treating Parkinson's disease.

Authors:  Venkatesan Dhivya; Vellingiri Balachandar
Journal:  Stem Cell Investig       Date:  2017-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.